Citation Impact
Citing Papers
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort
2009
A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder
1999
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
2009
Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials
2006
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
2010 Standout
Serotonin in the gastrointestinal tract
2009
Response to Corticosteroids in Severe Ulcerative Colitis: A Systematic Review of the Literature and a Meta-Regression
2006
Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction
2005
Bloating and Distention in Irritable Bowel Syndrome: The Role of Visceral Sensation
2008
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
2003 Standout
Bowel Disorders
2016 Standout
Influence of acute serotonin reuptake inhibition on colonic sensorimotor function in man
2005
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome
2005
LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin
2010
Microbial tryptophan catabolites in health and disease
2018 Standout
Ulcerative Colitis
2011 Standout
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
Genetic Approaches to Functional Gastrointestinal Disorders
2010
Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis
2007
Head and neck cancer
2008 Standout
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease
2004
Epidemiology of Non-Alcoholic Fatty Liver Disease
2010
Update on Nonalcoholic Fatty Liver Disease
2002
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
2010
Non‐alcoholic fatty liver disease: An overview
2002
The NAFLD fibrosis score
2007 Standout
Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation
2004
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Piezos thrive under pressure: mechanically activated ion channels in health and disease
2017 StandoutNobel
Altered 5-Hydroxytryptamine Signaling in Patients With Constipation- and Diarrhea-Predominant Irritable Bowel Syndrome
2006
Inflammation and Colon Cancer
2010 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
Measuring inconsistency in meta-analyses
2003 Standout
Ulcerative colitis
2012 Standout
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography
2011
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
2001
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin, and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS
2015
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Suicide and cancer: a gender-comparative study
2006
Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis
2014
Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease
2008
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets
2013
Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma
2011
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Ulcerative colitis
2016 Standout
Non‐alcoholic fatty liver disease – a common and benign finding in octogenarian patients
2004
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
2012
Review article: intestinal serotonin signalling in irritable bowel syndrome
2006
Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis
2016
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Prevalence of and risk factors for fatty liver in a general population of Shanghai, China
2005
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
2018 Standout
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
2007 Standout
Non-alcoholic fatty liver: another feature of the metabolicsyndrome?
1999
Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection
2007
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
The pros, cons, and many unknowns of probiotics
2019 Standout
Health‐related fitness and physical activity in patients with nonalcoholic fatty liver disease†‡
2008
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
1993
Interactions between human polymorphonuclear leukocytes and one strain of pathogenicLeptospira (L. interroganssp.) and one of saprophyticLeptospira (L. biflexasp.)
1983
The use of fecal calprotectin and lactoferrin in patients with IBD. Review.
2013
Irritable bowel syndrome: towards biomarker identification
2009
Interaction of leptospires with human polymorphonuclear neutrophils
1984
Irritable Bowel Syndrome
2015 Standout
Irritable bowel syndrome: the role of food in pathogenesis and management.
2014
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China.
2009
Nonalcoholic Fatty Liver Disease
2001 Standout
A four‐country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders
2014
Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)
2006
Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome
2012
Systematic review: the perceptions, diagnosis and management of irritable bowel syndrome in primary care - A Rome Foundation Working Team Report
2014
Leptospirosis
2001 Standout
Phagocytosis of virulent and avirulent leptospires by guinea-pig and human polymorphonuclear leukocytes in vitro
1984
Synthesis and Electrochemistry of 2-Ethenyl and 2-Ethanyl Derivatives of 5-Nitroimidazole and Antimicrobial Activity against Giardia lamblia
2009 StandoutNobel
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
2017
Phagocytosis as a defense mechanism against infection with leptospiras
1986
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
The vital link between chronic disease and depressive disorders.
2005
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
2013
Probiotics for the Prevention and Treatment of Antibiotic-Associated Diarrhea
2012
Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation
2013
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Serotonin, Inflammation, and IBS: Fitting the Jigsaw Together?
2007
Works of Massimo Bellini being referenced
The bright liver syndrome. Prevalence and determinants of a "bright" liver echopattern.
1997
Double-blind comparison of fluvoxamine and imipramine in depressed patients
1989
The genetics of the serotonin transporter and irritable bowel syndrome
2008
Altered neuro-endocrine–immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model
2012
The general practitioner's approach to irritable bowel syndrome: From intention to practice
2005
Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome
2014
Role of faecal calprotectin as non-invasive marker of intestinal inflammation
2003
Cognitive behavioural therapy for obesity: One-year follow-up in a clinical setting
2003
Platelet Serotonin Transporter in Patients With Diarrhea-Predominant Irritable Bowel Syndrome Both Before and After Treatment With Alosetron
2003
Helicobacter pylori Eradication: A Randomized Prospective Study of Triple Therapy Versus Triple Therapy Plus Lactoferrin and Probiotics
2007
S1265 Analysis of Cholecystokinin Type 1 Receptor Gene Polymorphisms in Patients with Irritable Bowel Syndrome
2009
Bimodal rehabilitation has a long lasting efficacy in pelvic floor dyssynergia
2000
The Role of Antibodies and Serum Complement in the Interaction between Macrophages and Leptospires
1982
Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation
2014
[Increased suicide risk in cancer patients].
1994